primary prevention of coeliac disease - Associazione Italiana ...

More documents

Recommendations

Info

72 MECHANISMS OF ORAL TOLERANCE 23. McCormick PA, Feighery C, Dolan C, O'Farrelly C, Kelleher P, Graeme-Cook F, et al. Altered gastrointestinal immune response in sarcoidosis. Gut 1988; 29: 1628- 31. 24. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, et al. Doubleblind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321-4. 25. Barnett ML, Combitchi D, Trentham DE. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum 1996; 39: 623-8. 26. Husby S, Jensenius JC, Svehag SE. Passage of undergraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand J Immunol 1986; 24: 447-52. 27. Zimmer KP, Poremba C, Weber P, Ciclitira PJ, Harms E. Translocation of gliadin into HLA-DR antigen containing lysosomes in coeliac disease enterocytes. Gut 1995; 36: 703-9. 28. Kelly J, Weir DG, Feighery CF. Differential expression of HLA-D gene products in the normal and coeliac small bowel. Tissue Antigens 1987; 31: 151-60. 29. Mayer L, Schlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 1987; 166: 1471-83. 30. Canchis PW, Bhan AK, Landau SB, Yang L, Balk SP, Blumberg RS. Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology 1993 ; 80: 561-5. 31. Byrne B, Madrigal-Estebas L, McEvoy A, Carton J, Doherty DG, O'Donoghue D, et al. Human duodenal epithelial cells constitutively express molecular components of antigen presentation but not costimulatory molecules. (2002, submitted). 32. Mowat AM. Regulation of Immune Responses to Dietary Protein Antigens. In: Gastrointestinal Immunology and Gluten-Sensitive Disease. Proceedings of the Sixth International Symposium on Coeliac Disease held at Trinity College Dublin, July 1992. Eds. Feighery C, O'Farrelly C. Publishers: Oak Tree Press, Dublin. 33. Madara JL. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 1998; 60: 143-59. 34. Feighery C, Weir DG, Whelan A, Willoughby R, Youngprapakorn S, Lynch S, et al. Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol 1998; 10: 919-25. 35. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995; 270: 1203-7. 36. Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994; 8: 2964-73. 37. Trier, J. S. Structure and function of intestinal M cells. Gastroenterol Clin North Am. 1991; 20: 531-47. 38. Hayday A, Theodoridis E, Ramsburg E, Shires J. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat Immunol 2001; 2: 997-1003. 39. Viney J, MacDonald T, Spencer J. Gamma delta T cells in the gut epithelium. Gut 1990: 31: 841-4. 40. Eiras P, Leon F, Camarero C, Lombardia M, Roldan E, Bootello A, et al. Intestinal intraepithelial lymphocytes contain a CD3 - CD7+ subset expressing natural killer markers and a singular pattern of adhesion molecules. Scand J Immunol 2000; 52:
MECHANISMS OF ORAL TOLERANCE 73 1-6. 41. Ke Y, Kapp JA. Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells and antibody responses which activating CD8+ suppressor T cells. J Immunol 1996; 156: 916-21. 42. Banchereau J, Briére F, Caux C, Davoust J, Lebecque S, Liu Y-J, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811. 43. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001; 106: 263-6. 44. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends in Immunol 2001; 22: 394-400. 45. Whelan CA. (personal communication). 46. Hogger P, Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 2001; 288: 841-3. 47. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737-42. 48. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-79. 50. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-b-mediated oral tolerance. J Exp Med 1996; 183: 2605-16. 50. Fishman-Lobell J, Friedman A, Weiner HL. Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur J Immunol 1994; 24: 2720-4. 51. Weijers HA, Lindquist B, Anderson CM, et al. Round table discussions. Diagnostic criteria in celiac disease. Acta Paediatr Scand 1970: 59: 461-3. 52. Walker-Smith JA. Transient gluten intolerance. Arch Dis Child 1970; 45: 523-6. 53. Schmitz J. Is celiac disease a lifelong disorder? Clin Invest Med 1996; 19: 352-6. 54. Ansaldi N, Tavassoli K, Faussone D, Forni M, Oderda G. Clinical-histological behavior of celiac patients after gluten load following the definitive diagnosis. Pediatr Med Chir 1988; 10: 3-6. 55. McNicholl B, Egan-Mitchell B, Fottrell PF. Variability of gluten intolerance in treated childhood coeliac disease. Gut 1979; 20: 126-32. 56. O'Mahony C. Immunological and Clinical Studies in Gluten Sensitive Disease. University College Dublin. MD Thesis 1986.
Page 1:
Perspectives on Coeliac Disease Vol
Page 4:
The AIC Meeting was held in the Aul
Page 8 and 9:
Italian Coeliac Society, Via Picott
Page 11 and 12:
Preface Coeliac disease (CD) is a u
Page 13:
Contents Current understanding of t
Page 16 and 17:
2 THE BASIS OF COELIAC DISEASE hapl
Page 18 and 19:
4 THE BASIS OF COELIAC DISEASE 1 pr
Page 20 and 21:
6 THE BASIS OF COELIAC DISEASE spre
Page 22 and 23:
8 THE BASIS OF COELIAC DISEASE Ackn
Page 24 and 25:
10 THE BASIS OF COELIAC DISEASE glu
Page 27 and 28:
Catassi C, Fasano A, Corazza GR (ed
Page 29:
T CELL RESPONSES TO GLUTEN PEPTIDES
Page 32 and 33:
18 A DOMINANT EPITOPE IN GLUTEN PEP
Page 34 and 35:
20 A DOMINANT EPITOPE IN GLUTEN PEP
Page 36 and 37: 22 A DOMINANT EPITOPE IN GLUTEN PEP
Page 42 and 43: 28 ROLE OF A-GLIADIN 31-49 PEPTIDE
Page 45 and 46: Catassi C, Fasano A, Corazza GR (ed
Page 47 and 48: COELIAC DISEASE IN THE SAHARAWI 33
Page 55: COELIAC DISEASE IN THE SAHARAWI 41
Page 58 and 59: 44 INFANT FEEDING PRACTICES AND COE
Page 66 and 67: Age (years) 52 INFANT FEEDING PRACT
Page 76 and 77: 62 MECHANISMS OF ORAL TOLERANCE the
Page 78 and 79: 64 MECHANISMS OF ORAL TOLERANCE pot
Page 80 and 81: 66 MECHANISMS OF ORAL TOLERANCE Epi
Page 82 and 83: 68 MECHANISMS OF ORAL TOLERANCE typ
Page 84 and 85: 70 MECHANISMS OF ORAL TOLERANCE 51
Page 91 and 92: GENETICALLY DETOXIFIED GRAINS 77 to
Page 93 and 94: • • GENETICALLY DETOXIFIED GRAI
Page 95 and 96: GENETICALLY DETOXIFIED GRAINS 81 3.
Page 99 and 100: IMMUNOTHERAPY OF COELIAC DISEASE 85
Page 101 and 102: IMMUNOTHERAPY OF COELIAC DISEASE 87
Page 105 and 106: RECENT ADVANCES ON GLUTEN TOXICITY
Page 107 and 108: Index A Antiendomysium antibodies (
Page 109: INDEX 95 W Wheat, 7, 23, 27, 31, 53
show all

primary prevention of coeliac disease - Associazione Italiana ...

Create successful ePaper yourself

Delete template?

Save as template?